TrialOpen forum infectious diseases2026

Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis.

Risa Hoffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.